指南与共识产科母胎医学

SMFM胎盘植入谱超声标志物工作组特别报告:标志物定义与超声检查方法共识

Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum.
指南 / 共识 · Am J Obstet Gynecol · 2021-01-01

胎盘植入谱包括胎盘粘连、植入、穿透等异常附着,发病率随剖宫产率上升而增加。产前超声检出对降低母体并发症重要,但文献中标志物定义不一致。母胎医学会召集多学科工作组,基于现有数据与专家共识评估超声标志物,提供高危妊娠子宫胎盘超声评估标准化方法,并识别研究空白。

要点

  • 胎盘植入谱涵盖粘连、植入、穿透等异常胎盘附着类型。
  • 产前超声是主要检出手段,对降低母体并发症重要。
  • 工作组旨在标准化标志物定义与高危妊娠超声评估方法。

核心结论

  • 工作组基于现有数据与专家共识评估胎盘植入谱超声标志物,并提供高危妊娠子宫胎盘超声评估的标准化方法。

研究设计与样本

  • 母胎医学会召集工作组,成员来自美国超声医学研究所、美国妇产科医师学会、美国放射学会、国际妇产科超声学会、超声放射医师学会、美国诊断医学超声注册机构和Gottesfeld-Hohler纪念超声基金会。

主要发现

  • 胎盘植入谱发病率近年增加,主要驱动因素为剖宫产率上升。
  • 产前检出主要依靠超声,对降低母体并发症重要。
  • 尽管研究众多,文献中胎盘植入谱超声标志物及其筛查性能的不一致性持续存在。

临床怎么用

  • 对胎盘植入谱高危妊娠,采用工作组提供的标准化方法进行产前超声评估子宫和胎盘。

局限性

  • 工作组识别了该领域的研究空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Placenta accreta spectrum includes the full range of abnormal placental attachment to the uterus or other structures, encompassing placenta accreta, placenta increta, placenta percreta, morbidly adherent placenta, and invasive placentation. The incidence of placenta accreta spectrum has increased in recent years, largely driven by increasing rates of cesarean delivery. Prenatal detection of placenta accreta spectrum is primarily made by ultrasound and is important to reduce maternal morbidity associated with the condition. Despite a large body of research on various placenta accreta spectrum ultrasound markers and their screening performance, inconsistencies in the literature persist. In response to the need for standardizing the definitions of placenta accreta spectrum markers and the approach to the ultrasound examination, the Society for Maternal-Fetal Medicine convened a task force with representatives from the American Institute of Ultrasound in Medicine, the American College of Obstetricians and Gynecologists, the American College of Radiology, the International Society of Ultrasound in Obstetrics and Gynecology, the Society for Radiologists in Ultrasound, the American Registry for Diagnostic Medical Sonography, and the Gottesfeld-Hohler Memorial Ultrasound Foundation. The goals of the task force were to assess placenta accreta spectrum sonographic markers on the basis of available data and expert consensus, provide a standardized approach to the prenatal ultrasound evaluation of the uterus and placenta in pregnancies at risk of placenta accreta spectrum, and identify research gaps in the field. This manuscript provides information on the Placenta Accreta Spectrum Task Force process and findings.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shainker SA, Coleman B, Timor-Tritsch IE, et al. Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol. 2021. PMID: 33386103. doi:10.1016/j.ajog.2020.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。